Search results
Sangamo Therapeutics Reports Q1 2024 Results: A Deep Dive into Financials and Strategic Highlights
GuruFocus.com via Yahoo Finance· 2 days agoThe anticipated mid-2024 pivotal readout of the Phase 3 AFFINE trial, a collaboration with Pfizer for hemophilia A treatment, could potentially lead to regulatory submissions ...
Sangamo Therapeutics Reports Q1 2024 Results: A Deep Dive into F
Guru Focus· 2 days agoSangamo Therapeutics Inc (SGMO, Financial), a leader in genomic medicine, disclosed its 8-K filing on May 9, 2024, revealing detailed insights into its first quarter financials and recent strategic ...
Regenxbio Inc (RGNX) Q1 2024 Earnings Call Transcript Highlights
Guru Focus· 4 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Regenxbio Inc (RGNX, Financial) reported strong microdystrophin expression across a wide ...